PHARMAJET

company

About

PharmaJet develops devices for fixed dose needle-free jet injection.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$800K
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jun 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

PharmaJet is a user-friendly, inexpensive device for fluid injection into the body without a needle. Able to compete with traditional needle-syringe delivery, which inherently poses costly needle-stick, re-use, and pass-along disease risk, the technology creates a positive ROI back for every injection. Unique in the field of jet injection because of its ability to reach all target tissues (IM, SC--0.5 mL, and ID--0.1 mL) accurately and comfortably, supported by wide regulatory claims (global and country-specific) PharmaJet's platforms are the only commercially available devices that effectively address the 3 B annual immunization market.

It was founded in 2005 and headquartered in Golden, Colorado.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$800K
PHARMAJET has raised a total of $800K in funding over 2 rounds. Their latest funding was raised on Nov 29, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 29, 2022 Grant $800K 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
PHARMAJET is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant